A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer
Michael T. Schweizer(Fred Hutch Cancer Center), Samuel R. Denmeade(Johns Hopkins University), Su Jin Lim(Johns Hopkins University), Jeffrey M. Karp(Broad Institute), Carolyn G. Chapman(Johns Hopkins University), W. Nathaniel Brennen(Johns Hopkins University), John T. Isaacs(Brady (Norway)), Neil A. Bhowmick(Cedars-Sinai Medical Center), Alan W. Partin(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Hao Wang(The University of Sydney), Rehab Abdallah(Johns Hopkins University), Oren Levy(Brigham and Women's Hospital), Angelo De Marzo(Johns Hopkins University)
Cited by 124
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Nanowired three-dimensional cardiac patches
|Nature Nanotechnology|2011|759
Role of EMT in Metastasis and Therapy Resistance
|Journal of Clinical Medicine|2016|493